2seventy bio Files 2024 10-K
| Field | Detail |
|---|---|
| Company | 2seventy Bio, Inc. |
| Form Type | 10-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
TL;DR
2seventy bio's 2024 10-K is in, check financials and strategy for the year.
AI Summary
2seventy bio, Inc. filed its 2024 10-K on March 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, located at 60 Binney Street, Cambridge, MA, operates in the Pharmaceutical Preparations sector. Key financial details and operational highlights for the year are presented in this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of 2seventy bio's financial performance, strategic initiatives, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a company in the pharmaceutical sector, 2seventy bio faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-25 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- 2seventy bio, Inc. (company) — Filer of the 10-K
- 60 BINNEY STREET, CAMBRIDGE, MA 02210 (company) — Business and Mail Address
- William Baird (person) — Member
- Marcela Maus (person) — Member
- Novo Nordisk (company) — Partner/Collaborator
- Regeneron (company) — Partner/Collaborator
FAQ
What were the total revenues for 2seventy bio in fiscal year 2024?
The filing indicates revenue figures for the fiscal year 2024, but specific total dollar amounts are not provided in this header information.
What is the primary business segment of 2seventy bio?
2seventy bio, Inc. is classified under the Pharmaceutical Preparations [2834] Standard Industrial Classification.
Who are some of the key partners or collaborators mentioned in the filing?
The filing mentions Novo Nordisk and Regeneron in relation to the fiscal years 2023 and 2024.
What is the state of incorporation for 2seventy bio?
2seventy bio, Inc. is incorporated in Delaware (DE).
When did 2seventy bio file its 10-K for the fiscal year ending December 31, 2024?
The 10-K was filed on March 25, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 25, 2025 by William Baird regarding 2seventy bio, Inc..